Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.006 Å; R factor = 0.032; wR factor = 0.076; data-to-parameter ratio = 15.7.
In the title compound, [Pd(C 5 H 14 N 2 O 3 P)Cl]ÁH 2 O, the Pd(II) atom shows a slightly distorted square-planar geometry and forms two five-membered metallacycles, which both exhibit half-chair conformations. The crystal structure consists of layers propogating in the [100] direction which are connected into a three-dimensional network by strong N-HÁ Á ÁCl, N-HÁ Á ÁO and O-HÁ Á ÁO hydrogen bonds.
Related literature
For general background to the use of organic phosphonic acids as chelating agents in metal extraction and as drugs for the prevention of calcification and bone resorption, see: MatczakJon & Videnova-Adrabinska (2005) ; Tromelin et al. (1986) ; Szabo et al. (2002) . For related structures, see: Shkol'nikova et al. (1991) .
Experimental
Crystal data [Pd(C 5 Table 1 Hydrogen-bond geometry (Å , ). Data collection: APEX2 (Bruker, 2005 ); cell refinement: SAINT (Bruker, 2005) ; data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: publCIF (Westrip, 2010) .
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: IM2173).
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Comment
Organic phosphonic acids are potentially very powerful chelating agents used in metal extractions and they are also tested by pharmaceutical industry for use as efficient drugs preventing calcification and inhibiting bone resorption (Tromelin et al., 1986 , Matczak-Jon & Videnova-Adrabinska, 2005 . Diphosphonic acids are used in the treatment of Paget disease, osteoporosis and tumoral osteolysis (Szabo et al., 2002) . The molecular structure of the title compound contains one molecule of the complex per asymmetric unit (Fig.1 ). The palladium atom shows a slightly distorted square-planar geometry. Mean average deviation from the respective plane is 0.040 (1) Å with a maximum deviation for O1 of 0.048 (1) The crystal structure of the title compound forms a layered supramolecular structure, stabilized by strong N-H···Cl, N-H···O and O-H···O hydrogen bonds (Fig.2, Table 1 ).
Experimental 2-(2-aminoethyl)aminopropan-2-yl-phosphonic acid hydrochloride (0.219 g, 1 mmol) in water (10 ml) was mixed together with a solution of palladium diacetate (0.224 g, 1 mmol, Merck ≥ 99%) in benzene (10 ml). The color of the aqueous phase of the reaction mixture slowly turned to pale yellow. After stirring for 12 h, the aqueous phase of the solution was separated.
Suitable single crystals of the title compound were produced by slow evaporation of water from an aqueous solution at room temperature (yield: 76%). A pale yellow needle-shaped crystal was used for data collection.
Refinement
H atoms bonded to N and O atoms were located in a difference map and refined with constrained U iso (H) = 1.2U eq (N,O).
Other H atoms were positioned geometrically and refined using riding model with C-H = 0.99 Å for CH 2 [U iso (H) = 1.2Ueq(C)] and C-H = 0.98 Å for CH 3 [U iso (H) = 1.5U eq (C)]. The DFIX instruction was used in the final refinement for restraining the O3-H3O distance to a reasonable value.
supplementary materials sup-2 Figures   Fig. 1 . The title compound showing 50% probability displacement ellipsoids for non-hydrogen atoms. 
